biomedicina slovenica


"FIBRINOLYSIS" : 123-222

  1. Sinkovič Andreja
    Utjecaj plasminogen-aktivator-inhibitora-1 na liječenje akutnog infarkta miokarda streptokinazom, aspirinom i heparinom
    1999
  2. Boh Marko
    Pomen holesterola HDL v normalnih in bolezenskih okoliščinah ter zdravljenje hipoalfalipoproteinemije
    [The significance of HDL cholesterol in health and disease, and therapy of hypoalphalipoproteinemia]
    2000
  3. Šebeštjen M; Žegura B; Gužič-Salobir B; Keber I
    Inzulinska rezistenca in zmanjšana fibrinolitična aktivnost: označevalca prebolelega miokardnega infarkta pri bolnikih s heterozigotno družinsko hiperholesterolemijo
    1999
  4. Boič M; Fermo I; Ritonja A; D'Angelo A; Peternel P; Stegnar M
    Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
    1998
  5. Stegnar M; Božič M; Fermo I; Ritonja A; D'Angelo A; Peternel P
    Association of mild hyperhomocysteinemia with fibrinolysis and resistance to activated protein C in venous thromboembolism
    1998
  6. Zore Andrej
    Fibrinolitična aktivnost krvi med nosečnostjo in porodom: vloga tkivnega aktivatorja plazminogena in njegovih inhibitorjev
    1992
  7. Thijs LG
    Coagulation disorders in sepsis
    1997
  8. Škrgat-Kristan Sabina; Meško-Brguljan Pika; Košnik Mitja; Šorli Jurij
    D-dimer v diagnostiki pljučne embolije
    [D-dimer in the diagnostic procedure of pulmonary embolism]
    1999
  9. Sinkovič Andreja
    Pretreatment plasminogen activator inhibitor-1 (PAI-1) levels and the outcome of thrombolysis with streptokinase in patients with acute myocardial infarction
    1998
  10. Mavri Alenka; Stegnar Mojca; Krebs Michael; Sentočnik Jožica T; Greiger Margarethe; Binder Bernard R
    Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
    1999
  11. Poredoš P; Stegnar M; Gačnik A
    Alternation of the fibrinolytic system in patients with peripheral arterial occlusive disease
    1999
  12. Blinc A; Fras Z; Stegnar M; Keber D
    Research in fibrinolysis and proteolysis is focusing on extracellular matrix degradation and vascular biology
    1999
  13. Žic L; Roškar Z; Kanič Z; Todorovič-Guid M; Bračič K; Miksić M; Pogorevc R
    Sindrom večorganske motnje delovanja in sindrom večorganske odpovedi pri otrocih - nekatere patofiziološke, klinične in terapevtske značilnosti
    [Multiple organ dysfunction syndrome and multiple organ failure syndrome in children - some of the pathophysiological, clinical and therapeutic characteristic]
    1998
  14. Poredoš Pavel; Videčnik Viktor
    LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions - a randomized controlled trial
    1999
  15. Lavrenčič Aleša
    Vpliv redne telesne vadbe na fibrinolitično aktivnost krvi in endotelijsko vazodilatacijo pri bolnikih z metaboličnim kardiovaskularnim sindromom
    1999
  16. Fras Zlatko
    Life-style in prevention of coronary artery disease
    1998
  17. Petrovič Danijel; Peterlin Borut
    Genetic polymorphism and coronary artery disease
    1998
  18. Stegnar M; Keber D; Peternel P
    Fibrinoliza: fiziologija in patofiziologija
    1992
  19. Stegnar Mojca; Uhrin Pavel; Peternel Polona; Mavri Alenka; Salobir-Pajnič Barbara; Stare Janez; Binder Bernd R
    The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism
    1998
  20. Blinc Aleš; Francis Charles W
    Transport processes in fibrinolysis and fibrinolytic therapy
    1996
  21. Stegnar M; Peternel P; Uhrin P; Cvelbar-Marinko T; Goršič-Tomažič K; Binder BR
    Fibrinolysis in patients with the 1691 G-A mutation in factor V gene and history of deep vein thrombosis
    1997
  22. Fras Zlatko
    Polimetabolni sindrom in razvoj ateroskleroze
    [Polymetabolic syndrome and the development of atherosclerosis]
    1998
  23. Poredoš Pavel
    Etiopatogeneza ateroskleroze
    [Pathogenesis of atherosclerosis]
    1998
  24. Andoljšek Dušan
    Hemostaza
    1998
  25. Gužič B; Mavri A; Stegnar M; Keber I; Stare J
    Seasonal fluctuation of haemostatic and metabolic variables in patients after acute myocardial infarction
    1997
  26. Pirc Borut
    Novosti v vaskularni biologiji
    1997
  27. Drobnič-Košorok M; Zrimšek P; Juntes P
    Endogenous proteinases and their protein inhibitors in normal and tumor cell
    1997
  28. Pernat A; Pohar B; Horvat M
    Effect of hydrocortisone on streptokinase-induced hypotension in patients with acute myocardial infarction
    1997
  29. Uršič-Bratina N
    Dejavniki tveganja za razvoj ateroskleroze pri otrocih staršev, ki so zboleli z miokardnim infarktom pred 45. letom starosti
    1994
  30. Zidanšek A; Blinc A; Lahajnar G; Keber D; Blinc R
    Finger-like lysing patterns of blood clots
    1995
  31. Stegnar M; Ambrožič J; Berger B; Keber I
    In vitro plasma and euglobulin clot lysis in subjects with elevated lipoprotein(a)
    1995
  32. Keber Dušan
    Overview of the fibrinolytic system in 1995
    1995
  33. Francis CW; Blinc A; Lee S; Cox C
    Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots
    1995
  34. Šmuc K; Štalc M
    Vpliv menstruacijskega ciklusa na teste hemostaze
    [The effect of menstrual cycle on hemostatic tests]
    1995
  35. Gužič B
    Metabolični in fibrinolitični učinki ovsenih vlaken v prehrani pri koronarnih bolnikih s sladkorno boleznijo tip 2
    1995
  36. Salobir-Pajnič B
    Koagulacija in fibrinoliza pri mladih ženskah, ki so prebolele trombembolijsko bolezen
    1995
  37. Aragon-Ortiz F; Gubenšek F
    Characterization of a metallo-proteinase from Bothrops asper (terciopelo) snake venom
    1987
  38. Stegnar M; Meglič A; Meglič L; Novak-Antolič Ž
    Fibrinolysis after delivery: caesarean section versus vaginal delivery
    1994
  39. Siddiqi F; Blinc A; Braaten J; Francis CW
    Ultrasound increases flow through fibrin gels
    1995
  40. Kashyap Ashwin; Blinc Aleš; Marder Victor J; Penney David P; Francis Charles W
    Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury
    1994
  41. Stegnar M; Mavri A
    Reproducibility of fibrinolytic response to venous occlusion in healthy subjects
    1995
  42. Šabovič M; Keber D
    In-vitro sinergism between t-PA and scu-PA depends on clot retraction
    1995
  43. Šabovič M
    Trombolitično zdravljenje (principi, mehanizem delovanja trombolitičnih sredstev in pogoji za uspešno raztapljanje)
    1994
  44. Peternel P
    Vpliv nekirurških rekanalizacijskih posegov na preživetje in kakovost življenja bolnikov s simptomatskimi oblikami ateroskleroze
    1994
  45. Stegnar M; Kozak M; Šabovič M
    D-Dimer during intra-arterial low-dose streptokinase treatment of pheripheral arterial occlusive disease
    1994
  46. Peternel P; Stegnar M; Mavri A; Salobir-Pajnič B
    The effect of fasting and/or body weight reduction on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1)
    1994
  47. Keber I; Lavre J; Šuc S; Keber D
    The decrease of plasminogen activator inhibitor after normalization of triglycerides during treatment with fibrates
    1994
  48. Gužič B; Sundell IB; Keber I; Keber D
    The effect of oat husk supplementation in diet on plasminogen activator inhibitor type I in diabetic survivors of myocardial infarction
    1994
  49. Stegnar M; Pentek M
    Age-related changes in the basal level of tissue-type plasminogen activator and plasminogen activator inhibitor 1
    1992
  50. Stegnar M; Keber I; Keber D; Peternel P
    Fibrinolytic potential in healthy men and in patients with thrombotic disease
    1987
  51. Poredoš P; Videčnik V; Šurlan M; Miklavčič L
    Local treatment of pripheral arterial occlusion disease with streptokinase and plasminogen
    1986
  52. Zidanšek A; Blinc A
    The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases
    1991
  53. Francis Charles W; Onundarson Pall T; Carstensen Edwin L; Blinc Aleš; Meltzer Richard S; Schwarz Karl; Marder Victor J
    Enhancement of fibrinolysis in vitro by ultrasound
    1992
  54. Keber I; Jereb M; Keber D
    Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity
    1987
  55. Stegnar Mojca; Peternel Polona; Keber Dušan; Vene Nina
    Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis
    1991
  56. Šabović M; Lijnen HR; Keber D; Collen D
    Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators
    1989
  57. Stegnar M; Peternel P; Chen JP
    Acute hypoxemia does not increase blood fibrinolytic activity in man
    1987
  58. Kremžar B
    Patofiziologija in zdravljenje motenj strjevanja krvi
    1994
  59. Ambrožič J; Berger B
    Vpliv lipoproteina(a) na fibrinolizo in vitro
    [The effect of lipoprotein(a) on fibrinolysis in vitro]
    1994
  60. Blinc Aleš
    Vpliv načina prenosa urokinaze v krvne strdke na njihovo raztapljanje
    1994
  61. Blinc A; Kennedy SD; Bryant RG; Marder VJ; Francis CW
    Flow through clots determines the rate and pattern of fibrinolysis
    1994
  62. Mavri A
    Stalnost fibrinolitičnega odgovora na venski zažem pri zdravih
    [Reproducibility of fibrinolytic response to venous occlusion in healthy volunteers]
    1993
  63. Zidanšek A; Blinc A; Lahajnar G; Keber D; Blinc R
    Lysing patterns of blood clots: a nuclear magnetic resonance imaging study in vitro and mathematical modelling of the lysing pattern kinetics
    1993
  64. Šabovič M
    Mehanizem fiziološkega in farmakološkega raztapljanja krvnih strdkov
    1992
  65. Stegnar M; Pentek M
    Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin (published erratum appears in Thromb Res 1993 Oct 15;72(2):173)
    1993
  66. Blinc Aleš; Francis Charles W; Trudnowski Janet L; Carstensen Edwin L
    Characterization of ultrasound-potentiated fibrinolysis in vitro
    1993
  67. Meglič A; Meglič L
    Sproščanje tkivnega aktivatorja plazminogena med porodom in po njem
    [Release of tissue plasminogen activator during and after delivery]
    1993
  68. Keber Irena; Keber Dušan; Stegnar Mojca; Vene Nina
    Tissue plasminogen activator release in chronic venous hypertension due to heart failure
    1992
  69. Keber I; Keber D
    Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis
    1992
  70. Keber I; Keber D
    Age-related increase of tissue plasminogen activator in healthy subjects and coronary pateints: increased basal release and diminished clearance
    1992
  71. Blinc A; Keber D; Lahajnar G; Zupančič I; Zorec-Karlovšek M; Demšar F
    Magnetic resonance imaging of retracted and nonretracted blood clots during fibrinolysis in vitro
    1992
  72. Lindič J; Pšeničnik M; Bren A; Guček A; Ferluga D; Kveder R
    The morphology of parietal peritoneum: a scanning electron micrograph study
    1993
  73. Stegnar M; Zore A; Novak-Antolič Ž; Vovk N; Kruithof EK
    Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium
    1993
  74. Stegnar Mojca; Božic Borut; Peternel Polona; Kveder Tanja; Vene Nina; Rozman Blaž
    Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
    1991
  75. Borovničar A
    Vpliv lipemije po maščobnem obroku na fibrinolitične inhibitorje
    1989
  76. Kluft C
    Congenital deficiencies in fibrinolysis
    1990
  77. Medcalf RL
    Regulation of gene expression of components of coagulation and fibrinolysis
    1990
  78. Kralj J
    Topljivost fibrinskog ugruška u otopini ureje
    1990
  79. Kralj J
    Liza euglobulinskog ugruška
    1990
  80. Guna P; Klemenc M; Kobal M; Regvat J; Snoj B
    Intervencijska radiologija
    1991
  81. Medvešček M; Keber D; Stegnar M; Borovničar A
    Plasminogen activator inhibitor-1 response to a carbohydrate meal in obese subjects
    1990
  82. Peternel P; Stegnar M; Salobir U; Salobir B; Keber D; Vene N
    Shift work and circadian rhythm of blood fibrinolytic parameters
    1990
  83. Poredoš P; Stegnar M; Gačnik A
    Basal and post-stimulation fibrinolytic activity in patients with peripheral arterial atherosclerotic disease
    1990
  84. Stegnar M; Dolžan N; Hojnik M; Peternel P
    The effect of hypoxia during exercise on release of tissue-type plasminogen activator (t-PA)
    1990
  85. Vene N; Stegnar M
    Tissue-type plasminogen activator and plasminogen activator inhibitor-1 after exercise: comparison to venous occlusion and DDAVP
    1990
  86. Stegnar M; Peternel P
    Prirojena trombofilija
    [Congenital thrombophilia]
    1990
  87. Videčnik V
    Vpliv intraartrijskega dajanja streptokinaze na fibrinolitično aktivnost krvi in druge koagulacijske parametre pri bolnikih z zaporo perifernih arterij
    1988
  88. Salobir U; Salobir B
    Dnevni ritem fibrinolitične aktivnosti krvi med nočnim in dnevnim delom
    [Diurnal rhythm of blood fibrinolytic activity during shift work]
    1989
  89. Stegnar M; Keber D; Pentek M; Vene N; Kluft C
    Age and sex diferences in resting and postocclusion values of tissue plasminogen activator in a healthy population
    1988
  90. Keber D
    Mechanism of tissue plasminogen activator release during venous occlusion
    1988
  91. Stegnar M; Keber D; Peternel P; Kluft C
    Diminished release of tissue plasminogen activator during venous occlusion in manual workers
    1988
  92. Kozak M
    Fibrinolitični potencial nog v akutnem in kroničnem obdobju globoke venske tromboze na nogi
    1988
  93. Vene Nada
    Sproščanje tkivnega aktivatorja plazminogena po draženju pri zdravih in pri bolnikih z vensko trombozo
    1989
  94. Kitek A; Gabrovec N
    Fibrinolitička aktivnost plazme kod bolesnika sa primarnom hiperholesterolemijom
    [Plasmatic fibrinolytic activity in primary hypercholesterolemia]
    1987
  95. Fras Z
    Ločeni in skupni učinek telesne aktivnosti in infuzije DDAVP na izplavljanje tkivnega aktivatorja
    [Separate and combined effect of physical exercise and infusion of DDAVP on the release of tissue plasminogen activator]
    1988
  96. Kulauzov M; Kulauzov M; Lucić A
    The fibrinolitic activity of Streptococcuss and hemolytic streptococci
    1986
  97. Možina H; Pušnar S
    Dnevni ritem sproščanja tkivnega aktivatorja plazminogena pri bolnikih s stalno srčno frekvenco
    [Diurnal rhythm of the tissue plasminogen activator (t-PA) release in patients with constant heart rate]
    1987
  98. Šabovič M; Štendler M; Keber D; Stegnar M; Rott T; Pirc B
    Raztapljanje strdkov "ex vivo" s tkivnim aktivatorjem plazminogena, streptokinazo in urokinazo
    [Dissolution of "ex vivo" thrombi by plasminogen activator, streptokinase and urokinase]
    1986
  99. Videčnik V; Šurlan M; Keber D
    Vpliv intraarterijskih majhnih doz streptokinaze na koagulacijo in fibrinolizo
    [The effect of intraarterial low dose streptokinase on coagulation and fibrinolysis]
    1986
  100. Keber I; Keber D
    Vpliv telesne dejavnosti na fibrinolitično aktivnost krvi in krožeče trombocitne agregate pri koronarnih bolnikih
    [The effect of physical training on blood fibrinolytic activity and circulating platelet aggregates in coronary patients]
    1986

   1 23 123 223  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics